...
首页> 外文期刊>Prescrire international >Elderly dementia patients and neuroleptics: excess mortality
【24h】

Elderly dementia patients and neuroleptics: excess mortality

机译:老年痴呆症患者和抗精神病药:死亡率过高

获取原文
获取原文并翻译 | 示例
           

摘要

In 2005, a meta-analysis conducted by the US Food and Drug Administration showed a 1% to 2% increase in mortality, in absolute values, in elderly dementia patients treated with so-called atypical neuroleptics than in patients not receiving neuroleptics.One placebo-controlled trial, two new meta-analyses, and several cohort studies of various sizes and designs have been published since 2005.The double-blind placebo-controlled trial showed a statistically significant decline in mortality when neuroleptic therapy (hsperidone or haloperidol in most cases) was withdrawn. One of the meta-analyses showed excess mortality in patients receiving atypical neuroleptics compared with those not receiving neuroleptics. The other meta-analysis, focusing solely on risperidone, showed a higher risk of vascular death than in placebo-treated patients. Four very large cohort studies also showed a trend towards excess mortality with conventional neuroleptics. In practice, as all neuroleptics have negative risk-benefit balances in elderly dementia patients, it is best to avoid using them in these patients, if possible. If a neuroleptic is nonetheless prescribed, treatment should be for the shortest possible duration, at the minimum effective dose.
机译:2005年,美国食品药物管理局进行的一项荟萃​​分析显示,使用所谓的非典型抗精神病药治疗的老年性痴呆患者的绝对价值死亡率比未接受抗精神病药的患者增加了1%至2%。自2005年以来,已发表了一项对照试验,两项新的荟萃分析以及几项各种规模和设计的队列研究。双盲安慰剂对照试验显示,在精神安定治疗(大多数情况下使用潘定酮或氟哌啶醇)后死亡率有统计学意义的下降)已撤回。一项荟萃分析显示,与不接受抗精神病药的患者相比,接受非典型抗精神病药的患者死亡率高。另一项仅关注利培酮的荟萃分析显示,与安慰剂治疗的患者相比,血管死亡的风险更高。四个非常大的队列研究也显示了常规抗精神病药会导致死亡率过高的趋势。在实践中,由于所有的抗精神病药在老年痴呆症患者中均具有负面的风险收益平衡,因此,如果可能的话,最好避免在这些患者中使用它们。如果仍使用抗精神病药,则​​应以最小有效剂量在最短时间内进行治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号